These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Agranulocytosis during phenindione therapy. AGER JA; INGRAM GI Br Med J; 1957 May; 1(5027):1102-3. PubMed ID: 13426555 [No Abstract] [Full Text] [Related]
3. Severe drug sensitivity reaction to phenindione (phenylindandione). MAKOUS N; VANDER VEER JB J Am Med Assoc; 1954 Jun; 155(8):739-41. PubMed ID: 13162792 [No Abstract] [Full Text] [Related]
4. Agranulocytosis and scarlatiniform eruption due to phenindione. PASTOR BH; TETREAULT AF J Am Med Assoc; 1956 Jun; 161(9):873-4. PubMed ID: 13319027 [No Abstract] [Full Text] [Related]
5. Severe sensitivity reaction (hepatitis, dermatitis and pyrexia) attributable to phenylindanedione. EAST EN; BEAMISH RE Can Med Assoc J; 1957 Dec; 77(11):1028-30. PubMed ID: 13489594 [No Abstract] [Full Text] [Related]
7. Sensitivity to phenindione: report of a case. JOHNMAN L Scott Med J; 1957 Aug; 2(8):330-1. PubMed ID: 13467298 [No Abstract] [Full Text] [Related]
8. Oral hemorrhage secondary to the use of varidase buccal tablets (streptokinase-streptodornase) in conjunction with anticoagulant therapy with hedulin (phenindione); (case report). BENSHOFF AM W V Med J; 1959 Nov; 55():397. PubMed ID: 13798990 [No Abstract] [Full Text] [Related]
9. Skin sensitivity to phenindione. Report of a case. Dalley D; Kelleher PR N Z Med J; 1966 Aug; 65(408):535-8. PubMed ID: 4224160 [No Abstract] [Full Text] [Related]